The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Departed by the sprawling virus for nearly two years, Wondfo is eager to meet you in AACC 2022 during July 26-28. We are well prepared for your visit at booth 3148 in McCormick Place Convention Center in Chicago.
During AACC 2022, you may expect to see:
1. Accre System
● Ready to use with single-dose reagent cartridge
● Flexible and convenient with all-in-one design
● Room-temperature running
● 600-day MTBF, 28-day calibration interval
● Lower cost by 30-50% than traditional CLIA machines
2. FINECARE™ FIA System
● Broad test menu, covering infection & inflammation, thyroid, hormone, oncology, diabetes, renal injury, cardiac diseases, vitamin, coagulation, craniocerebral injury, etc
● Convenient operation with portable machine
● Room-temperature stable
● Well distributed locally and globally